Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Sunday, May 31, 2015

CME/CE activity - New Challenges Facing Multiple Sclerosis Nurses

From Medscape Education Neurology & Neurosurgery

New Challenges Facing Multiple Sclerosis Nurses CE

Constance B. Easterling, RN, MSN, ANP, MSCN; Aliza Ben-Zacharia, DrNP, ANP-BC, MSCN; Megan R. Weigel, DNP, ARNP-C, MSCN
 
CE Released: 05/29/2015 ; Valid for credit through 05/29/2016

This activity is intended for nurses and nurse practitioners engaged in the care of patients with multiple sclerosis (MS) and related disorders.
The goal of this activity is to provide an overview of MS pathology, symptomatology, and the risks and benefits of currently available disease-modifying therapies and other therapeutic approaches.
Upon completion of this activity, participants will be able to:
  1. Review current understanding of the pathology and natural history of MS
  2. Compare and contrast the mechanisms of action, risks, and benefits of available disease-modifying therapies
  3. Discuss complications of MS and strategies for managing them to improve outcomes and enhance patients' quality of life

Faculty and Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Constance B. Easterling, MSN, ARNP, MSCN

Clinical Coordinator, Multiple Sclerosis Care Center of Neurological Services Orlando, Orlando, Florida
Disclosure: Constance B. Easterling, MSN, ARNP, MSCN, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Biogen Idec Inc.; Genzyme Corporation; Pfizer
Served as a speaker or a member of a speakers bureau for: Acorda Therapeutics; Biogen; EMD Serono, Inc.; Genzyme Corporation; Mallinckrodt; Pfizer Inc; Teva Pharmaceuticals USA

Ms Easterling does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Ms Easterling does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Aliza Ben-Zacharia, RN, ANP, DrNP

Neurology Teaching Assistant, Icahn School of Medicine at Mount Sinai, New York, New York
Disclosure: Aliza Ben-Zacharia, RN, ANP, DrNP, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer HealthCare Pharmaceuticals; Biogen; Genentech, Inc.; Genzyme Corporation; Novartis Pharmaceuticals Corporation; Questcor Pharmaceuticals, Inc.; Teva Pharmaceuticals USA
Received grants for clinical research from: Biogen Idec Inc.; Novartis Pharmaceuticals Corporation

Dr Ben-Zacharia does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Ben-Zacharia does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Megan Weigel, DNP, ARNP-C, MSCN

Nurse Practitioner, Baptist Neurology, Baptist Health, Jacksonville, Florida
Disclosure: Megan Weigel, DNP, ARNP-C, MSCN has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Biogen; Genentech, Inc.; Genzyme Corporation; Mallinckrodt
Served as a speaker or a member of a speakers bureau for: Acorda Therapeutics; Bayer HealthCare Pharmaceuticals; Biogen Idec Inc.; Genzyme Corporation; Mallinckrodt, Novartis Pharmaceuticals Corporation; Pfizer Inc; EMD Serono, Inc.; Teva Pharmaceuticals USA

Dr Weigel does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Weigel does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Ron Schaumburg, MA

Scientific Director, Medscape, LLC
Disclosure: Ron Schaumburg, MA, has disclosed no relevant financial relationships.

Amy Bernard, MS, BSN, RN-BC

Lead Nurse Planner, Medscape, LLC
Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:
  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


CME  Link:  http://www.medscape.org/viewarticle/845035?src=wnl_edit_tpal






~~~~~~~~~~~~~~~~~~~~
 Keep CURRENT with MS Views and NewsOPT-IN here


.
.


No comments: